Andrew Hykes - 20 Mar 2023 Form 4 Insider Report for Inari Medical, Inc.

Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
20 Mar 2023
Net transactions value
-$578,610
Form type
4
Filing time
21 Mar 2023, 16:35:29 UTC
Previous filing
14 Mar 2023
Next filing
04 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $462,096 -7,200 -1.3% $64.18 554,083 20 Mar 2023 Direct F1, F2
transaction NARI Common Stock Sale $116,514 -1,800 -0.32% $64.73 552,283 20 Mar 2023 Direct F1, F3, F4
holding NARI Common Stock 1,550 20 Mar 2023 By Child 1
holding NARI Common Stock 1,550 20 Mar 2023 By Child 2
holding NARI Common Stock 1,550 20 Mar 2023 By Child 3
holding NARI Common Stock 1,000 20 Mar 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $63.58 to $64.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $64.61 to $64.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Balance includes 171 shares acquired under the Company's Employee Stock Purchase Plan.